

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.96521224 |
| 2 | eosinophil chemotaxis (GO:0048245) | 5.91266979 |
| 3 | regulation of mononuclear cell migration (GO:0071675) | 5.67289675 |
| 4 | regulation of macrophage chemotaxis (GO:0010758) | 5.29341951 |
| 5 | eosinophil migration (GO:0072677) | 5.23917135 |
| 6 | * response to zinc ion (GO:0010043) | 5.15622037 |
| 7 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.90885101 |
| 8 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.90885101 |
| 9 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 4.79936151 |
| 10 | angiotensin maturation (GO:0002003) | 4.66746786 |
| 11 | glycosphingolipid catabolic process (GO:0046479) | 4.42226318 |
| 12 | apoptotic cell clearance (GO:0043277) | 4.41726366 |
| 13 | * response to cadmium ion (GO:0046686) | 4.27407617 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.24393413 |
| 15 | epoxygenase P450 pathway (GO:0019373) | 4.23905291 |
| 16 | glycolipid catabolic process (GO:0019377) | 4.18168312 |
| 17 | monocyte chemotaxis (GO:0002548) | 4.10650699 |
| 18 | barbed-end actin filament capping (GO:0051016) | 4.05659491 |
| 19 | phospholipid efflux (GO:0033700) | 4.05529822 |
| 20 | peptide catabolic process (GO:0043171) | 3.96562458 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.89270967 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.89005491 |
| 23 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.88029954 |
| 24 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.84583593 |
| 25 | cellular response to ethanol (GO:0071361) | 3.83353530 |
| 26 | response to peptidoglycan (GO:0032494) | 3.82045548 |
| 27 | negative regulation of cholesterol transport (GO:0032375) | 3.73781389 |
| 28 | negative regulation of sterol transport (GO:0032372) | 3.73781389 |
| 29 | respiratory burst (GO:0045730) | 3.70626166 |
| 30 | cellular extravasation (GO:0045123) | 3.61394623 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 3.58778178 |
| 32 | macrophage differentiation (GO:0030225) | 3.57408654 |
| 33 | ceramide catabolic process (GO:0046514) | 3.50966403 |
| 34 | membrane lipid catabolic process (GO:0046466) | 3.44512265 |
| 35 | response to thyroid hormone (GO:0097066) | 3.35464283 |
| 36 | monocyte differentiation (GO:0030224) | 3.29113869 |
| 37 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.29004036 |
| 38 | sphingolipid catabolic process (GO:0030149) | 3.27123857 |
| 39 | regulation of vitamin metabolic process (GO:0030656) | 3.26987617 |
| 40 | fructose metabolic process (GO:0006000) | 3.26239947 |
| 41 | vitamin biosynthetic process (GO:0009110) | 3.24833497 |
| 42 | granulocyte chemotaxis (GO:0071621) | 3.24627805 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24495819 |
| 44 | oligosaccharide catabolic process (GO:0009313) | 3.21309697 |
| 45 | regulation of podosome assembly (GO:0071801) | 3.17643868 |
| 46 | adhesion of symbiont to host cell (GO:0044650) | 3.17566114 |
| 47 | virion attachment to host cell (GO:0019062) | 3.17566114 |
| 48 | omega-hydroxylase P450 pathway (GO:0097267) | 3.16587387 |
| 49 | granulocyte migration (GO:0097530) | 3.12541117 |
| 50 | response to copper ion (GO:0046688) | 3.11105964 |
| 51 | regulation of cholesterol homeostasis (GO:2000188) | 3.06079423 |
| 52 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.04629888 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 3.03659323 |
| 54 | response to magnesium ion (GO:0032026) | 3.03173177 |
| 55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.99792784 |
| 56 | modulation by symbiont of host immune response (GO:0052553) | 2.99792784 |
| 57 | positive regulation by symbiont of host defense response (GO:0052509) | 2.99792784 |
| 58 | modulation by symbiont of host defense response (GO:0052031) | 2.99792784 |
| 59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.99792784 |
| 60 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.99792784 |
| 61 | intracellular pH reduction (GO:0051452) | 2.99194113 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98055923 |
| 63 | glucose 6-phosphate metabolic process (GO:0051156) | 2.95430917 |
| 64 | complement activation, alternative pathway (GO:0006957) | 2.94759209 |
| 65 | pH reduction (GO:0045851) | 2.93866872 |
| 66 | cholesterol efflux (GO:0033344) | 2.92422245 |
| 67 | positive regulation of cholesterol efflux (GO:0010875) | 2.92383143 |
| 68 | immunoglobulin mediated immune response (GO:0016064) | 2.92248201 |
| 69 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88366360 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 2.87265568 |
| 71 | protein-lipid complex remodeling (GO:0034368) | 2.85911568 |
| 72 | macromolecular complex remodeling (GO:0034367) | 2.85911568 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 2.85911568 |
| 74 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84152692 |
| 75 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.83479937 |
| 76 | decidualization (GO:0046697) | 2.79658367 |
| 77 | phagosome maturation (GO:0090382) | 2.78826116 |
| 78 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.78257067 |
| 79 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.78214316 |
| 80 | neutrophil chemotaxis (GO:0030593) | 2.77882874 |
| 81 | NADH metabolic process (GO:0006734) | 2.76826600 |
| 82 | neutrophil migration (GO:1990266) | 2.73633095 |
| 83 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.72601233 |
| 84 | acute-phase response (GO:0006953) | 2.70451551 |
| 85 | adhesion of symbiont to host (GO:0044406) | 2.67176386 |
| 86 | lymphocyte chemotaxis (GO:0048247) | 2.65513150 |
| 87 | regulation of lymphocyte migration (GO:2000401) | 2.64783352 |
| 88 | glial cell migration (GO:0008347) | 2.64476456 |
| 89 | regulation of apoptotic cell clearance (GO:2000425) | 2.60323632 |
| 90 | urea metabolic process (GO:0019627) | 2.60139551 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 2.59097492 |
| 92 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.59081067 |
| 93 | macrophage activation involved in immune response (GO:0002281) | 2.58027448 |
| 94 | granulocyte activation (GO:0036230) | 2.57715953 |
| 95 | vitamin D metabolic process (GO:0042359) | 2.56047813 |
| 96 | positive regulation of phagocytosis (GO:0050766) | 2.54895576 |
| 97 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.53905601 |
| 98 | nitrogen cycle metabolic process (GO:0071941) | 2.53689074 |
| 99 | * cellular response to zinc ion (GO:0071294) | 15.0565321 |
| 100 | * cellular response to cadmium ion (GO:0071276) | 10.9543438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.78821725 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.16541202 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.74253443 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.06654237 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.80974418 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.73473226 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71172930 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64274692 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54090656 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50956693 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.40788528 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.30701739 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30682806 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27366402 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15874004 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.07253589 |
| 17 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.01199696 |
| 18 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.96837663 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.92937148 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.90706395 |
| 21 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.90384379 |
| 22 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.89391100 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86222045 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77724811 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75371309 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72127863 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.71935713 |
| 28 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.70914821 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61560730 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.60856098 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59233249 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59172469 |
| 33 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52258824 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49889592 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49531157 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49343176 |
| 37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48242130 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48048747 |
| 39 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47103679 |
| 40 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.45915834 |
| 41 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43052766 |
| 42 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40244136 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38586954 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38322157 |
| 45 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38177568 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38043946 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33243998 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28892998 |
| 49 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.27975301 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26210594 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25571591 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24826693 |
| 53 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.24372566 |
| 54 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.22714696 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.22246648 |
| 56 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22173312 |
| 57 | SA1_27219007_Chip-Seq_Bcells_Human | 1.21353642 |
| 58 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20345740 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19369770 |
| 60 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19287819 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16761252 |
| 62 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.16503740 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16126753 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14102937 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13587778 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13521321 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12825762 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12800263 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12232941 |
| 70 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12178916 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12024985 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11846660 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09402203 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09276081 |
| 75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.07861323 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06662093 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06124044 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05994804 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05413041 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04888417 |
| 81 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03944526 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03386796 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03110313 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03079413 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02383956 |
| 86 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.02031097 |
| 87 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01005359 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00493844 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00408602 |
| 90 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00387488 |
| 91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00009393 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 0.97875547 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96137547 |
| 94 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.94962853 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94807855 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94335207 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94254091 |
| 98 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.93983028 |
| 99 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92904852 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92732494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 5.27103180 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.55049421 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.47270890 |
| 4 | MP0009785_altered_susceptibility_to | 3.37480390 |
| 5 | MP0009278_abnormal_bone_marrow | 3.30867105 |
| 6 | MP0003436_decreased_susceptibility_to | 3.29546256 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.06768978 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 3.03297215 |
| 9 | MP0003195_calcinosis | 2.94374994 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.92964591 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.91431806 |
| 12 | MP0005365_abnormal_bile_salt | 2.85128268 |
| 13 | MP0005360_urolithiasis | 2.73495595 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.62177911 |
| 15 | MP0009764_decreased_sensitivity_to | 2.53586597 |
| 16 | MP0000343_altered_response_to | 2.50494088 |
| 17 | MP0002419_abnormal_innate_immunity | 2.36675290 |
| 18 | MP0003075_altered_response_to | 2.25211217 |
| 19 | MP0001853_heart_inflammation | 2.20889482 |
| 20 | MP0002254_reproductive_system_inflammat | 2.14743132 |
| 21 | MP0000604_amyloidosis | 2.09234708 |
| 22 | MP0006082_CNS_inflammation | 2.00270078 |
| 23 | MP0005025_abnormal_response_to | 1.95759113 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.95022283 |
| 25 | MP0008260_abnormal_autophagy | 1.91246124 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.85103628 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.84730655 |
| 28 | MP0002998_abnormal_bone_remodeling | 1.82188393 |
| 29 | MP0003303_peritoneal_inflammation | 1.77161071 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.77064678 |
| 31 | MP0001790_abnormal_immune_system | 1.75198570 |
| 32 | MP0005387_immune_system_phenotype | 1.75198570 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.73667332 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.70034966 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.68365565 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.68365565 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.57531038 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.55277569 |
| 39 | MP0008469_abnormal_protein_level | 1.52031710 |
| 40 | MP0005671_abnormal_response_to | 1.50576057 |
| 41 | MP0005166_decreased_susceptibility_to | 1.48696616 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.47870265 |
| 43 | MP0004510_myositis | 1.43050622 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.39775191 |
| 45 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39416695 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.38201520 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.32777200 |
| 48 | MP0003828_pulmonary_edema | 1.31789118 |
| 49 | MP0001849_ear_inflammation | 1.31344225 |
| 50 | MP0003448_altered_tumor_morphology | 1.28734434 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.28716833 |
| 52 | MP0003329_amyloid_beta_deposits | 1.27648894 |
| 53 | MP0009765_abnormal_xenobiotic_induced | 1.26622387 |
| 54 | MP0000858_altered_metastatic_potential | 1.26130753 |
| 55 | MP0005023_abnormal_wound_healing | 1.23212083 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.22912130 |
| 57 | MP0005310_abnormal_salivary_gland | 1.22858426 |
| 58 | MP0003690_abnormal_glial_cell | 1.19902246 |
| 59 | MP0002723_abnormal_immune_serum | 1.17935677 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.16663051 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.15420848 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.12509135 |
| 63 | MP0000685_abnormal_immune_system | 1.09526383 |
| 64 | MP0005332_abnormal_amino_acid | 1.08929851 |
| 65 | MP0001819_abnormal_immune_cell | 1.07084799 |
| 66 | MP0001764_abnormal_homeostasis | 1.06794849 |
| 67 | MP0009763_increased_sensitivity_to | 1.05461706 |
| 68 | MP0002420_abnormal_adaptive_immunity | 1.04407375 |
| 69 | MP0005451_abnormal_body_composition | 1.04211201 |
| 70 | MP0003186_abnormal_redox_activity | 1.03892676 |
| 71 | MP0008874_decreased_physiological_sensi | 1.01592262 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.01441520 |
| 73 | MP0001800_abnormal_humoral_immune | 1.01220191 |
| 74 | MP0000920_abnormal_myelination | 0.99290776 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.99238771 |
| 76 | MP0004233_abnormal_muscle_weight | 0.96122393 |
| 77 | MP0000609_abnormal_liver_physiology | 0.91299606 |
| 78 | MP0005257_abnormal_intraocular_pressure | 0.88045984 |
| 79 | MP0005595_abnormal_vascular_smooth | 0.87634561 |
| 80 | MP0002405_respiratory_system_inflammati | 0.86321181 |
| 81 | MP0004883_abnormal_blood_vessel | 0.86036892 |
| 82 | MP0003795_abnormal_bone_structure | 0.85846277 |
| 83 | MP0004947_skin_inflammation | 0.85630247 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.82390121 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 0.81215684 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.79118955 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78976695 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.78105948 |
| 89 | MP0000249_abnormal_blood_vessel | 0.75170584 |
| 90 | MP0000750_abnormal_muscle_regeneration | 0.74319030 |
| 91 | MP0000678_abnormal_parathyroid_gland | 0.73257230 |
| 92 | MP0003279_aneurysm | 0.71930283 |
| 93 | MP0003724_increased_susceptibility_to | 0.70622738 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.68866003 |
| 95 | MP0005164_abnormal_response_to | 0.67168707 |
| 96 | MP0000490_abnormal_crypts_of | 0.65748803 |
| 97 | MP0005390_skeleton_phenotype | 0.65031631 |
| 98 | MP0002933_joint_inflammation | 0.64259690 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.62624538 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.62138916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.83700566 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 5.40734815 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.40734815 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.40734815 |
| 5 | Malnutrition (HP:0004395) | 5.05909691 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.91226576 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.68232438 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.67584164 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.56284323 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.54002757 |
| 11 | Xanthomatosis (HP:0000991) | 4.36272035 |
| 12 | Complement deficiency (HP:0004431) | 4.24791393 |
| 13 | Metaphyseal irregularity (HP:0003025) | 4.20108009 |
| 14 | Glomerulonephritis (HP:0000099) | 3.99338563 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.89795830 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.80492954 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.72983841 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.70735491 |
| 19 | Increased serum ferritin (HP:0003281) | 3.69124091 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.52016345 |
| 21 | Abnormality of complement system (HP:0005339) | 3.45257518 |
| 22 | Loss of speech (HP:0002371) | 3.25548994 |
| 23 | Mutism (HP:0002300) | 3.17385177 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.13290713 |
| 25 | Nausea (HP:0002018) | 3.12887496 |
| 26 | Abnormality of proline metabolism (HP:0010907) | 3.07360620 |
| 27 | Hydroxyprolinuria (HP:0003080) | 3.07360620 |
| 28 | Dysostosis multiplex (HP:0000943) | 3.02979085 |
| 29 | Neurofibrillary tangles (HP:0002185) | 3.00996592 |
| 30 | Abnormality of iron homeostasis (HP:0011031) | 2.95167796 |
| 31 | Retinal atrophy (HP:0001105) | 2.94446148 |
| 32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.92862714 |
| 33 | Premature loss of primary teeth (HP:0006323) | 2.87975690 |
| 34 | Delayed epiphyseal ossification (HP:0002663) | 2.79077549 |
| 35 | Hypophosphatemia (HP:0002148) | 2.78324359 |
| 36 | Hematochezia (HP:0002573) | 2.74511234 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.74204720 |
| 38 | Myocardial infarction (HP:0001658) | 2.70729437 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.67199720 |
| 40 | Widely patent fontanelles and sutures (HP:0004492) | 2.61089708 |
| 41 | Thin bony cortex (HP:0002753) | 2.58726670 |
| 42 | Gingivitis (HP:0000230) | 2.57671871 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56084785 |
| 44 | Obstructive lung disease (HP:0006536) | 2.56084785 |
| 45 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.53202665 |
| 46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.53201476 |
| 47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.53201476 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.53201476 |
| 49 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.53184218 |
| 50 | Progressive visual loss (HP:0000529) | 2.53138303 |
| 51 | Bone pain (HP:0002653) | 2.51720926 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.51461083 |
| 53 | Pathologic fracture (HP:0002756) | 2.47809064 |
| 54 | Petechiae (HP:0000967) | 2.47347147 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.46563801 |
| 56 | Amyloidosis (HP:0011034) | 2.46557824 |
| 57 | Protuberant abdomen (HP:0001538) | 2.44536453 |
| 58 | Recurrent skin infections (HP:0001581) | 2.36627993 |
| 59 | Conjunctival telangiectasia (HP:0000524) | 2.34115534 |
| 60 | Disinhibition (HP:0000734) | 2.33736351 |
| 61 | Nephritis (HP:0000123) | 2.31933700 |
| 62 | Purpura (HP:0000979) | 2.31472637 |
| 63 | Symptomatic seizures (HP:0011145) | 2.31279494 |
| 64 | Elevated alkaline phosphatase (HP:0003155) | 2.27148410 |
| 65 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.24773035 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24200839 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.24200839 |
| 68 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.23775938 |
| 69 | Axonal loss (HP:0003447) | 2.22259129 |
| 70 | Hypobetalipoproteinemia (HP:0003563) | 2.11344285 |
| 71 | Short femoral neck (HP:0100864) | 2.07242545 |
| 72 | Abnormality of the costochondral junction (HP:0000919) | 2.03156535 |
| 73 | Abnormal trabecular bone morphology (HP:0100671) | 2.01714955 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.01506520 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 1.98943717 |
| 76 | Visceral angiomatosis (HP:0100761) | 1.97447610 |
| 77 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.96353989 |
| 78 | Prolonged partial thromboplastin time (HP:0003645) | 1.94636921 |
| 79 | Dementia (HP:0000726) | 1.94059621 |
| 80 | Prolonged neonatal jaundice (HP:0006579) | 1.93425310 |
| 81 | Upper motor neuron abnormality (HP:0002127) | 1.91534184 |
| 82 | Cerebral hemorrhage (HP:0001342) | 1.90680850 |
| 83 | Hypertriglyceridemia (HP:0002155) | 1.87629847 |
| 84 | Bone cyst (HP:0012062) | 1.83811491 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 1.83051512 |
| 86 | Hemoptysis (HP:0002105) | 1.82425358 |
| 87 | Wide cranial sutures (HP:0010537) | 1.81191976 |
| 88 | Pancreatitis (HP:0001733) | 1.80038962 |
| 89 | Hemangiomatosis (HP:0007461) | 1.78456419 |
| 90 | Irritability (HP:0000737) | 1.78207520 |
| 91 | Abnormality of the periventricular white matter (HP:0002518) | 1.77301158 |
| 92 | Abdominal distention (HP:0003270) | 1.77231479 |
| 93 | Multiple enchondromatosis (HP:0005701) | 1.76639084 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 1.76312580 |
| 95 | Flat occiput (HP:0005469) | 1.76083471 |
| 96 | Recurrent pneumonia (HP:0006532) | 1.75603976 |
| 97 | Esophageal varix (HP:0002040) | 1.75539890 |
| 98 | Fat malabsorption (HP:0002630) | 1.74422098 |
| 99 | Enlarged epiphyses (HP:0010580) | 1.73589732 |
| 100 | Urticaria (HP:0001025) | 1.72970756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.14739052 |
| 2 | BLK | 3.80758276 |
| 3 | ACVR1B | 3.72366294 |
| 4 | TGFBR2 | 3.35852539 |
| 5 | ERN1 | 3.32622516 |
| 6 | RIPK4 | 2.92548288 |
| 7 | MATK | 2.78985657 |
| 8 | PBK | 2.61932547 |
| 9 | DDR2 | 2.55140944 |
| 10 | FGR | 2.48825608 |
| 11 | IRAK3 | 2.46331905 |
| 12 | CSK | 2.26694248 |
| 13 | LMTK2 | 2.17627447 |
| 14 | PRKG2 | 2.17373824 |
| 15 | TYK2 | 2.07005267 |
| 16 | TESK2 | 2.03691603 |
| 17 | CSF1R | 1.92093162 |
| 18 | TGFBR1 | 1.67925860 |
| 19 | TESK1 | 1.61177021 |
| 20 | MAP3K14 | 1.59130080 |
| 21 | TAOK2 | 1.55927408 |
| 22 | GRK7 | 1.55286758 |
| 23 | MAP3K11 | 1.54053913 |
| 24 | ABL2 | 1.46258907 |
| 25 | MAP3K13 | 1.44474678 |
| 26 | SMG1 | 1.43505556 |
| 27 | PDK2 | 1.39380590 |
| 28 | TAOK1 | 1.37323104 |
| 29 | MAP3K3 | 1.36017699 |
| 30 | PAK4 | 1.34744839 |
| 31 | PRPF4B | 1.34680647 |
| 32 | CDC42BPA | 1.32608868 |
| 33 | CAMK1D | 1.32471238 |
| 34 | LIMK1 | 1.24181274 |
| 35 | MAP4K1 | 1.16235994 |
| 36 | LYN | 1.14959151 |
| 37 | CAMKK2 | 1.10721232 |
| 38 | EPHB2 | 1.09811841 |
| 39 | ARAF | 1.08719776 |
| 40 | EEF2K | 1.06686543 |
| 41 | TBK1 | 1.05143133 |
| 42 | BMX | 1.01109101 |
| 43 | IKBKB | 0.99052378 |
| 44 | MAP3K1 | 0.98029507 |
| 45 | RPS6KL1 | 0.96126920 |
| 46 | RPS6KC1 | 0.96126920 |
| 47 | IRAK4 | 0.96035819 |
| 48 | MAP2K3 | 0.94451818 |
| 49 | BCKDK | 0.93479795 |
| 50 | RPS6KA2 | 0.90956220 |
| 51 | RIPK1 | 0.86119336 |
| 52 | TYRO3 | 0.85600038 |
| 53 | KDR | 0.84594848 |
| 54 | MAP2K6 | 0.84447631 |
| 55 | ZAP70 | 0.80694226 |
| 56 | JAK3 | 0.78923934 |
| 57 | OXSR1 | 0.77743581 |
| 58 | RPS6KA6 | 0.77478129 |
| 59 | ADRBK2 | 0.74728894 |
| 60 | MAP3K8 | 0.74446040 |
| 61 | IKBKE | 0.70492429 |
| 62 | PDPK1 | 0.68927176 |
| 63 | ALK | 0.63086481 |
| 64 | KSR2 | 0.61951993 |
| 65 | FES | 0.60914588 |
| 66 | DAPK2 | 0.58894711 |
| 67 | TNIK | 0.55325013 |
| 68 | FGFR4 | 0.55313420 |
| 69 | STK16 | 0.52760886 |
| 70 | CDK19 | 0.51395368 |
| 71 | SYK | 0.49983101 |
| 72 | LCK | 0.46603021 |
| 73 | PRKCD | 0.41567131 |
| 74 | PRKACG | 0.37799762 |
| 75 | PRKAA2 | 0.35771105 |
| 76 | PAK1 | 0.35448609 |
| 77 | HCK | 0.35065145 |
| 78 | MAP3K6 | 0.34841461 |
| 79 | BRAF | 0.34027908 |
| 80 | PDGFRA | 0.33978048 |
| 81 | SRC | 0.33855812 |
| 82 | MAP3K9 | 0.33725049 |
| 83 | RPS6KA1 | 0.32470566 |
| 84 | KIT | 0.30784269 |
| 85 | PDK1 | 0.29991210 |
| 86 | CAMK4 | 0.29917101 |
| 87 | STK4 | 0.29028208 |
| 88 | CAMK1G | 0.28938798 |
| 89 | VRK2 | 0.28885264 |
| 90 | PRKCA | 0.27694474 |
| 91 | FYN | 0.27117064 |
| 92 | JAK2 | 0.26732363 |
| 93 | PRKCG | 0.26266236 |
| 94 | MARK3 | 0.24389520 |
| 95 | CSNK2A1 | 0.23643211 |
| 96 | MAPK12 | 0.23221592 |
| 97 | PTK6 | 0.22838504 |
| 98 | MOS | 0.22519167 |
| 99 | TNK2 | 0.21900699 |
| 100 | DAPK3 | 0.21256823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Mineral absorption_Homo sapiens_hsa04978 | 4.96080891 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.58352201 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.80176218 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.69196244 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.61294928 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.57239466 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.37050733 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.32723455 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.90526316 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.87003908 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.84552827 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 1.79828129 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75966424 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.74296486 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.68579769 |
| 16 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.62589408 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61214244 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60323366 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59927551 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57534494 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54990719 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.52555084 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51048368 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.49349619 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.48928944 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48047910 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.47256577 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.42615270 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41005805 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39959532 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.39571405 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.34201655 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33743095 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31492612 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.29464958 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28910477 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28066230 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27048285 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.25614631 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21655803 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21195375 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19249638 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18968998 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18576694 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13597100 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13258857 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.09400797 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.05904694 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05041129 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.04498711 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01746439 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00947294 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98914773 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97742722 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94894694 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93553318 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92890542 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90921968 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90700047 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89792529 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87972098 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86374789 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81240288 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76951711 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75979994 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75017988 |
| 67 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73645353 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73315264 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.72542816 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71819290 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70266082 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69723603 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66216057 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64697599 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61119286 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 0.60843667 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60406407 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57212785 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56754449 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.56740405 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55895099 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52885118 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52557995 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46840976 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45955443 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45786253 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42566163 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.40390734 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39949102 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38495263 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.37628382 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36650144 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36134826 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35461051 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.34361136 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.32902616 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32362573 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31814635 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31051827 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29735163 |

